Joint Lab BeJEL receives 1.4 million EUR grant
The Berlin Joint EPR Laboratory (BeJEL) operated by HZB and Freie Universität Berlin has pulled in six of 27 subprojects within a DFG priority program to address“New Frontiers in Sensitivity for EPR Spectroscopy – from Biological Cells to Nano Materials”.
Electron spins are unique probes for materials and life sciences, and can be detected through electron paramagnetic resonance (EPR). The functioning of molecular machines, or the electronic properties of solar cells as well as catalytic chemical reactions, for example, can be determined at BeJEL using this method. To further enhance the sensitivity and resolution of EPR, the DFG Priority Programme SPP-1601 “New Frontiers in Sensitivity for EPR Spectroscopy – from Biological Cells to Nano Materials” has now been extended for a further three years through grants totalling 7.9 million EUR. In addition, DFG will make available 500,000 EUR to further expand collaboration with EPR groups in the USA.
Berlin-based BeJEL successfully pulled in six of the total 27 project grants within the competitive SPP Priority Programme selection process. With the help of 1.4 million EUR in DFG funding, BeJEL will now be in a position to push EPR into the terahertz region, implement ultra-high vacuum sample environments, develop miniature resonators and novel spin labels for investigating proteins in biological cells and study charge transport processes in inorganic and organic solar cells.
“The new financial stimulus from the DFG SPP Priority Programme considerably strengthens Berlin as an EPR site”, says Prof. Robert Bittl, official spokesperson for BeJEL. “In addition, we will be able to undertake new collaborative projects with our partners in Germany and the USA to achieve our ambitious goal of detecting even very small spin ensembles in the systems we are investigating”, adds Prof. Klaus Lips from HZB.
The six individual projects will be undertaken by the following BeJEL project leaders: Prof. Jan Behrends (Freie Universität Berlin/HZB), Prof. Robert Bittl (Freie Universität Berlin), Prof. Enrica Bordignon (Freie Universität Berlin), Prof. Klaus Lips (HZB), Prof. Thomas Risse (Freie Universität Berlin), and Dr. Alexander Schnegg (HZB).
More information on BeJEL
More Information on the research project: www.spp1601.de
- Green hydrogen: MXenes shows talent as catalyst for oxygen evolutionThe MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
- SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beerThe first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
- Review on ocular particle therapy (OPT) by international expertsA team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.